Clinical Trial

An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This research study is looking into the effects of clavulanic on smoking behavior in adult cigarette smokers. The primary study hypothesis is that, compared to placebo, clavulanic acid will reduce smoking over the course of the study.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2018-10-17; most recent amendment 2025-10-24.
Status change: Not Yet Recruiting → Recruiting 2019-04-02
Trial Details
NCT Number NCT03713424
Lead Sponsor University of Missouri-Columbia
Conditions Tobacco Use Disorder
Enrollment 30 participants
Start Date 2019-03-26
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-28